Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with a single‑assay design, intended to rule in and rule out amyloid pathology across primary and secondary care, offering faster diagnosis for millions of patients around the world.1,2,5 While maintaining accuracy comparable to spinal fluid diagnostics against the gold standard PET-CT scans, the Elecsys® pTau217 test offers a more convenient, minimally invasive alternative via a routine blood draw.1,2,4,7,8,11 Diagnosing dementia currently takes 3.5 years on average,11 and an estimated 75% of people living with dementia remain undiagnosed.6,9,11 Elecsys® pTau217 offers a simple blood test to aid in earlier, more accessible Alzheimer’s disease diagnosis for millions of patients around the world.1,2,4,5,7,8Basel, 12 May 2026 – Roche (SIX: RO, ROP;...

A partnership deployed in International Markets including Africa, Asia Pacific, Middle East, Turkey, South & Southeast Europe and Switzerland. Paris, France, and Dubai, United Arab Emirates, May 12, 2026 — Atos, a global leader in AI-powered digital transformation, today announced the signing of a Master Collaboration Agreement with Backbase, the creator of the AI-Native Banking OS. The agreement strengthens collaboration between the two companies to support financial institutions in accelerating AI-native transformation while maintaining control, compliance, and resilience in increasingly complex and regulated environments across International Markets including Africa, Asia Pacific, Middle East, Portugal, Spain, Southeast Europe, Switzerland and Turkey. As Financial institutions are under increasing pressure to innovate with AI...

BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) — North American lithium producer Elevra Lithium Limited (“Elevra or Company”) (ASX:ELV; NASDAQ:ELVR) announced today the outcomes of an Updated Scoping Study for expansion of the existing North American Lithium (NAL) mine. Relative to the study from 15 September 20251 this study delivers additional annual concentrate production two years faster than originally planned, similar unit operating costs and unchanged total capital expenditure of US$270 million. HighlightsProcess plant design feed rate increased to the permitted average annual 4,500 tonnes per day (tpd) in Stage 1 and 6,500 tpd in Stage 2; average Life of Mine (LOM) recovery of 71.2%; spodumene concentrate at grade of 5.4% Li2O.The updated Scoping Study improves the incremental post-tax NPV(8%) of the expansion...

LONDON, May 12, 2026 (GLOBE NEWSWIRE) — Rapid Nutrition PLC (Euronext Growth: ALRPD), a global HealthTech company advancing wellness through evidence-based, personalized nutrition solutions, today announced the expansion of its technology platform to its consumer-facing ecosystem, following a successful rollout within its investor communications infrastructure. The Company is extending these capabilities across its flagship SystemLS brand, enabling a more responsive and personalized approach to consumer health and wellness engagement. The platform delivers structured, on-demand guidance across nutrition, products, and lifestyle — available 24/7 in a private, confidential environment. As consumer expectations increasingly flavor personalized health solutions, the system is designed to translate product and nutritional information...

TORONTO, May 11, 2026 (GLOBE NEWSWIRE) — Hampton Financial Corporation (“Hampton” or the “Company”)(TSXV:HFC) today announced the acquisition of a 10% stake in dry bulk shipping company, ICON Energy Corp. (“Icon Energy”)(ICON:NASDAQ) Hampton has acquired a 10% stake in Icon Energy in open market transactions.  The purchases of an aggregate of 325,000 common shares of Icon Energy are for investment purposes.  The total investment by Hampton was approximately C$550,000. Icon Energy is an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. Icon Energy maintains its principal executive office in Athens, Greece, and its common shares trade on the Nasdaq Capital Market under the symbol “ICON.” Icon Energy owns 3 dry bulk vessels...

Enlitic’s Ensight Goes Live at RHCNZEnlitic, a global leader in radiology and imaging data, today announced the successful go-live of its Ensight platform at RHCNZ Medical Imaging Group (RHCNZ), New Zealand’s largest private radiology provider.LOVELAND, Colo., May 11, 2026 (GLOBE NEWSWIRE) — Enlitic, a global leader in radiology and imaging data, today announced the successful go-live of its Ensight platform at RHCNZ Medical Imaging Group (RHCNZ), New Zealand’s largest private radiology provider. The deployment marks Enlitic’s first customer in New Zealand and represents a significant milestone in the company’s continued global expansion. RHCNZ reads more than one in three radiology scans performed in New Zealand and operates more than 65 clinics across the country under the Auckland Radiology, Bay Radiology and Pacific...

Partnership combines venture creation and biologics discovery to accelerate novel medicines through human clinical proof of concept First-of-its-kind collaboration between a specialist biotech venture firm and a publicly-traded biopharma Initial focus on autoimmune diseases using bi- and tri-specific antibody approaches that combine novel and de-risked targets and mechanismsCAMBRIDGE, Mass. and TAIPEI, Taiwan, May 11, 2026 (GLOBE NEWSWIRE) — Delos Capital (“Delos”) and AP Biosciences, Inc. (“APBio”), today announced a strategic collaboration to create and incubate new biotechnology companies. The parties’ initial focus is the discovery and development of novel immune-related drug candidates through early clinical proof of concept. The model leverages Delos’ track record in building and leading biotech companies with APBio’s...